BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8332383)

  • 1. Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes.
    Lopez HM; Tanner MK; Kierszenbaum F; Sztein MB
    Parasite Immunol; 1993 May; 15(5):273-80. PubMed ID: 8332383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of Trypanosoma cruzi-induced immunosuppression. Altered expression by activated human lymphocytes of molecules which regulate antigen recognition and progression through the cell cycle.
    Kierszenbaum F; Moretti E; Sztein MB
    Biol Res; 1993; 26(1-2):197-207. PubMed ID: 7670532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of Trypanosoma cruzi on the transcription of the p55IL-2R, c-fos, c-myc and CD69 genes in activated human lymphocytes.
    Kierszenbaum F; Majumder S; Mejia Lopez H; Sztein MB
    Parasite Immunol; 1995 Apr; 17(4):197-205. PubMed ID: 7624160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes.
    Beltz LA; Kierszenbaum F; Sztein MB
    Infect Immun; 1989 Aug; 57(8):2301-5. PubMed ID: 2663720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypanosoma cruzi-induced decrease in the level of interferon-gamma receptor expression by resting and activated human blood lymphocytes.
    Kierszenbaum F; Mejia Lopez H; Tanner MK; Sztein MB
    Parasite Immunol; 1995 Apr; 17(4):207-14. PubMed ID: 7624161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?
    Kierszenbaum F; Mejia Lopez H; Sztein MB
    Immunology; 1993 Nov; 80(3):445-50. PubMed ID: 8288318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi induces suppression of DNA synthesis and inhibits expression of interleukin-2 receptors by stimulated human B lymphocytes.
    Kierszenbaum F; Moretti E; Sztein MB
    Immunology; 1991 Oct; 74(2):317-22. PubMed ID: 1748480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes.
    Kierszenbaum F; de Diego JL; Fresno M; Sztein MB
    Eur J Immunol; 1999 May; 29(5):1684-91. PubMed ID: 10359123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
    Majumder S; Kierszenbaum F
    J Immunol; 1996 May; 156(10):3866-74. PubMed ID: 8621925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
    Galvão da Silva AP; de Almeida Abrahamsohn I
    Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi suppresses the expression of the p75 chain of interleukin-2 receptors on the surface of activated helper and cytotoxic human lymphocytes.
    Kierszenbaum F; Sztein MB
    Immunology; 1992 Mar; 75(3):546-9. PubMed ID: 1533390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease.
    Kierszenbaum F
    Immunology; 1981 Nov; 44(3):641-8. PubMed ID: 6797934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection.
    Hayes MM; Kierszenbaum F
    Infect Immun; 1981 Mar; 31(3):1117-24. PubMed ID: 6785238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of lymphocyte responsiveness to polyclonal activators during acute and chronic experimental Trypanosoma cruzi infection.
    Kierszenbaum F; Hayes MM
    Am J Trop Med Hyg; 1980 Jul; 29(4):708-10. PubMed ID: 6773431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.